Le rein de l'enfant face à la chimiothérapie [The kidney in children under chemotherapy].


Autoria(s): Cachat F.; Guignard J.P.
Data(s)

1996

Resumo

Nowadays more and more children survive after an intensive anti-tumoral therapy. The price to pay consists of numerous and relatively frequent long-term sequelae (secondary tumors, neuropsychological deficits, endocrine or cardiac damage). After chemotherapy, we sometimes observe renal side-effects, either tubular (metabolic acidosis, hypokalemia, hypomagnesemia, proteinuria, Fanconi syndrome, rickets) or glomerular (acute or chronic decreased GFR). These renal toxic side-effects are encountered especially after cisplatinum and ifosfamide, less frequently after carboplatin and cyclophosphamide. The pediatrician has to be aware of these toxic nephrologic side-effects, to look out for them and monitor carefully the renal function of all paediatric patients receiving these potentially nephrotoxic chemotherapies.

Identificador

http://serval.unil.ch/?id=serval:BIB_1D067B31B465

isbn:0035-3655 (Print)

pmid:9026889

Idioma(s)

fr

Fonte

Revue Médicale de la Suisse Romande, vol. 116, no. 12, pp. 985-993

Palavras-Chave #Antineoplastic Agents/adverse effects; Antineoplastic Agents/toxicity; Antineoplastic Agents, Alkylating/adverse effects; Carboplatin/adverse effects; Child; Cisplatin/adverse effects; Glomerular Filtration Rate/drug effects; Humans; Ifosfamide/adverse effects; Kidney/drug effects; Kidney Diseases/chemically induced; Kidney Diseases/diagnosis; Kidney Function Tests; Methotrexate/adverse effects; Mitomycin/adverse effects; Semustine/adverse effects
Tipo

info:eu-repo/semantics/review

article